Bor, W. L.
, Zheng, K. L., Tavenier, A. H., Gibson, C. M., Granger, C. B., Bentur, O., Lobatto, R., Postma, S., Coller, B. S.
, van 't Hof, A. W. J., & Ten Berg, J. M. (2021).
Pharmacokinetics, pharmacodynamics, and tolerability of subcutaneous administration of a novel glycoprotein IIb/IIIa inhibitor, RUC-4, in patients with ST-segment elevation myocardial infarction.
Eurointervention,
17(5), 401-410.
https://doi.org/10.4244/EIJ-D-21-00287